These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 28948599)
1. Apoptosis and proliferation of the prostate cells in men with benign prostatic hyperplasia and concomitant metabolic disorders. Rył A; Rotter I; Kram A; Teresiński L; Słojewski M; Dołęgowska B; Lubkowska A; Piasecka M; Laszczyńska M Histol Histopathol; 2018 Apr; 33(4):389-397. PubMed ID: 28948599 [TBL] [Abstract][Full Text] [Related]
2. Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome. Ryl A; Rotter I; Slojewski M; Dolegowska B; Grabowska M; Baranowska-Bosiacka I; Laszczynska M Folia Histochem Cytobiol; 2015; 53(3):227-35. PubMed ID: 26400665 [TBL] [Abstract][Full Text] [Related]
3. [Effect of hypertension on cell proliferation and apoptosis in benign prostatic hyperplasia]. Li PJ; Zhang XH; Guo LJ; Na YQ Zhonghua Nan Ke Xue; 2005 Feb; 11(2):94-7. PubMed ID: 15755024 [TBL] [Abstract][Full Text] [Related]
4. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Kyprianou N; Tu H; Jacobs SC Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310 [TBL] [Abstract][Full Text] [Related]
5. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia. Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490 [TBL] [Abstract][Full Text] [Related]
6. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. Claus S; Berges R; Senge T; Schulze H J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363 [TBL] [Abstract][Full Text] [Related]
7. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666 [TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Hammarsten J; Högstedt B Eur Urol; 2001 Feb; 39(2):151-8. PubMed ID: 11223674 [TBL] [Abstract][Full Text] [Related]
9. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats. Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629 [TBL] [Abstract][Full Text] [Related]
10. Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia. Erdoğru T; Ciftcioglu MA; Emreoglu I; Usta MF; Koksal T; Ozbilim G; Gulkesen KH; Baykara M Urol Int; 2002; 69(4):287-92. PubMed ID: 12444285 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition. Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390 [TBL] [Abstract][Full Text] [Related]
12. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis. Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529 [TBL] [Abstract][Full Text] [Related]
14. [FEATURES OF CLINICAL COURSE AND MORPHOMETRIC PARAMETERS OF BENIGN PROSTATIC HYPERPLASIA IN MEN WITH METABOLIC SYNDROME AND ANDROGEN DEFICIENCY]. Tyuzikov IA; Grekov EA; Kalinchenko SY Urologiia; 2015; (5):66-9. PubMed ID: 26859941 [TBL] [Abstract][Full Text] [Related]
15. Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)? Rył A; Rotter I; Słojewski M; Jędrzychowska A; Marcinowska Z; Grabowska M; Laszczyńska M Int J Environ Res Public Health; 2015 Mar; 12(3):3327-42. PubMed ID: 25809513 [TBL] [Abstract][Full Text] [Related]
16. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia. Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391 [TBL] [Abstract][Full Text] [Related]
17. Insulin-resistance and benign prostatic hyperplasia: the connection. Vikram A; Jena G; Ramarao P Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919 [TBL] [Abstract][Full Text] [Related]